The Valley Desk

Clinical trial reportJournal for immunotherapy of cancerPublished

Treatment-free survival and partitioned survival analysis of patients with advanced renal cell carcinoma treated with nivolumab plus ipilimumab versus sunitinib: 5-year update of CheckMate 214

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Fox Chase Cancer Center, Temple Health. Affiliation source

Publication record

Type
Clinical trial report
Venue
Journal for immunotherapy of cancer
Published
Subject terms
Humans; Carcinoma, Renal Cell; Kidney Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Survival Analysis; Adult; Aged; Middle Aged; Female; Male; Ipilimumab; Sunitinib
PubMed ID
39060019
PubMed Central ID
PMC11284827
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal